clarithromycin has been researched along with 2019 Novel Coronavirus Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosogaya, N; Ishii, H; Izumikawa, K; Mukae, H; Sakamoto, N; Yamamoto, K; Yanagihara, K; Yatera, K; Yoshida, H | 1 |
| Barceló, D; Borja, Á; de Alda, ML; Larreta, J; López-García, E; Postigo, C; Rodríguez, JG; Solaun, O; Zonja, B | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Kandilarov, N; Markovska, R; Yordanov, D | 1 |
| Ellakany, WI; Ghazy, RM; Ismail, A; Kamal, A; Sherief, D | 1 |
| Bonilla-Aldana, DK; Fernandez-Suarez, H; Mendoza, LA; Millan, W; Millán-Oñate, J; Rodríguez-Morales, AJ; Sánchez, CG | 1 |
| Martingano, D; Mitrofanova, A; Nguyen, A; Nkeih, C; Singh, S | 1 |
| Abdelmaksoud, AA; Aref, ZF; Bazeed, SES; Hassan, MH; Mansour, H; Nafady, A; Nafady-Hego, H; Rashad, A; Sayed, MAA; Taya, U | 1 |
3 trial(s) available for clarithromycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study).
Topics: Clarithromycin; COVID-19; Humans; Multicenter Studies as Topic; Oxygen; Pandemics; Porphyrins; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome | 2021 |
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; COVID-19; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Pandemics; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Therapeutic efficacy of macrolides in management of patients with mild COVID-19.
Topics: Adult; Azithromycin; Clarithromycin; COVID-19; COVID-19 Drug Treatment; Female; Fever; Humans; Male; Middle Aged; Patient Acuity; Treatment Outcome | 2021 |
4 other study(ies) available for clarithromycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Antibiotics in the Basque coast (N Spain): Occurrence in waste and receiving waters, and risk assessment (2017-2020).
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; COVID-19; Ecosystem; Environmental Monitoring; Fluoroquinolones; Humans; Penicillins; Risk Assessment; Spain; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2022 |
Geographic distribution of antibiotic resistance of Helicobacter pylori: A study in Bulgaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; COVID-19; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Pandemics | 2023 |
Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.
Topics: Adult; Betacoronavirus; Chloroquine; Clarithromycin; Colombia; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Clarithromycin use for adjunct surgical prophylaxis before non-elective cesarean deliveries to adapt to azithromycin shortages in COVID-19 pandemic.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cesarean Section; Clarithromycin; COVID-19; Drug Substitution; Female; Humans; Pandemics; Pregnancy; Prospective Studies; Young Adult | 2020 |